For US residents only.

BRAF POSITIVE. TAF+MEK TOUGH.

TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets combination therapy has been proven effective in clinical trials of patients with BRAF+ melanoma after surgery as well as those with BRAF+ advanced melanoma. Explore this website to learn more about if treatment with TAFINLAR + MEKINIST is right for you, as well as available savings and support offerings.

Important Safety Information:

TAFINLAR® (dabrafenib) capsules and MEKINIST® (trametinib) tablets may cause serious side effects, including the risk of new cancers: TAFINLAR, when used in combination with MEKINIST, may ca...

See More
Approved Uses:

TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat people with a type of skin cancer called melanoma:

  • That has spread to other parts of the body (metastatic) or cannot be removed by surgery (unresectable), and
  • That has a certain type of abnormal "...
See More
About

BRAF+ melanoma

What is a BRAF mutation, and how can a positive genetic test for one expand your treatment options? Learn why targeted therapies for BRAF+ melanoma, such as TAFINLAR + MEKINIST, may be right for you.

LEARN MORE
About

TAFINLAR + MEKINIST

TAFINLAR + MEKINIST is a targeted therapy for both patients with BRAF+ melanoma after surgery to prevent it from coming back and patients with BRAF+ advanced melanoma.

LEARN MORE